Table 4.
ARF + | ARF – | Sensitivity (95% CI) | Specificity (95% CI) | PPV (95% CI) | NPV (95% CI) | |
---|---|---|---|---|---|---|
Patients 12-30 months | ||||||
Spot referral/positive | 27 | 13 | 81.8 | 56.7 | 67.5 | 73.9 |
Spot pass/negative | 6 | 17 | (68.1, 91.0) | (40.6, 71.7) | (53.5, 79.4) | (56.3, 86.8) |
Patients 31-48 months | ||||||
Spot referral/positive | 23 | 10 | 82.1 | 76.2 | 69.7 | 86.5 |
Spot pass/negative | 5 | 32 | (67.3, 91.7) | (63.2, 86.1) | (54.5, 82.0) | (74.6, 93.8) |
Patients >48 months | ||||||
Spot referral/positive | 164 | 25 | 89.6 | 80.3 | 86.8 | 84.3 |
Spot pass/negative | 19 | 102 | (84.9, 93.2) | (73.2, 86.2) | (81.7, 90.8) | (77.5, 89.6) |
P value, age group compare | 0.136 | 0.011 | 0.001 | 0.360 |
ARF, amblyopia risk factors; CI, confidence interval; NPV, negative predictive value; PPV, positive predictive value.